+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Octapharma AG - logo

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. It develops human proteins that are derived from human plasma and human cell-lines. The company provides biopharmaceutical products and therapies for haematology, intensive care & emergency medicine, and immunotherapy. Octapharma owns and operates six state of the art plants, employing over 6,000 workers globally. It was founded in 1983 by Wolfgang Marguerre.

Hemophilia Treatment - Global Strategic Business Report - Product Thumbnail Image

Hemophilia Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 476 Pages
  • Global
From
From
Rare Hemophilia Factors Market 2024-2028 - Product Thumbnail Image

Rare Hemophilia Factors Market 2024-2028

  • Report
  • July 2024
  • 142 Pages
  • Global
From
Hemophilia Market Report 2025 - Product Thumbnail Image

Hemophilia Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator